Skip to main content
Home

Top menu InfoLep

  • About InfoLep

Main navigation

  • Home
  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day 2022
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Antimicrobial resistance in leprosy
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [5]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
  • Publications
  • Organizations

Top menu - mobile infoLep

  • About InfoLep

Search

Refine your results

Refine your results


Selected filters

  • Reset filters
  • 2021
  • 2017
  • Immunoprophylaxis / Vaccine

Filter by type

  • Publications only

NTD

  • Leprosy (Hansen disease) (28)
  • Chagas disease (American trypanosomiasis) (1)

Subject

  • (-) Immunoprophylaxis / Vaccine (30)
  • Mycobacterium indicus pranii (MIP) (5)
  • Contacts / Contact tracing (4)
  • Tuberculosis (4)
  • Comorbidity (1)
  • COVID-19 (2)
  • Diagnostic tests (2)
  • Preventive Chemotherapy (PC) (5)
  • Dapsone (1)
  • HIV/AIDS (1)
  • Costs / Cost-effectiveness of interventions (1)
  • Armadillos (2)
  • SDR-PEP (2)
  • Squirrels (1)
  • Erythema nodosum leprosum - enl (Type 2 reaction) (2)
  • Social Economic Rehabilitation (1)
  • Transmission (3)
  • Public health (1)
  • Nonhuman sources of leprosy (1)
  • Case detection (2)
  • Complications and reactions (2)
  • Multi-drug therapy (MDT) (1)
  • Neglected tropical diseases (NTDs) (3)
  • Health & Development (1)
  • Health systems factors (1)
  • Integrated approach (1)
  • Epidemiology (5)
  • Prevention of disease (8)
  • Diagnosis (3)
  • Management of disease complication (3)
  • Treatment (4)
  • Drug resistance (2)
  • Disability (1)
  • Prevention of disability (pod) (1)
  • Self-care (1)
  • Rehabilitation (1)
  • Mortality (1)
  • Mental health (1)
  • Stigma (leprosy related) (1)
  • Discriminatory laws & Legislation (1)
  • Human rights (1)

Publication Type

  • Article (29)
  • Case study (1)
  • Full text online (23)
  • Global leprosy strategy (1)
  • Report (1)
  • Systematic review (2)
  • WHO publication (1)

Journal

  • Anais brasileiros de dermatologia (1)
  • Anais do Congresso Brasileiro de Imunologia On-line (1)
  • Biologics : targets & therapy (1)
  • Ciencia & saude coletiva (1)
  • Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases (1)
  • Epidemiology and health (1)
  • Immunological reviews (1)
  • Indian journal of dermatology, venereology and leprology (1)
  • International journal of dermatology (1)
  • International Journal of Vaccine Research (1)
  • Iranian journal of veterinary research (1)
  • Journal of medical discovery (1)
  • Journal of the European Academy of Dermatology and Venereology : JEADV (1)
  • Open Journal of Immunology (1)
  • PLoS neglected tropical diseases (5)
  • Science (New York, N.Y.) (1)
  • Scientific reports (2)
  • The Indian journal of medical research (1)
  • The journal of venomous animals and toxins including tropical diseases (1)
  • The Lancet. Global health (1)
  • The Lancet. Infectious diseases (2)
  • Vaccine (2)

Year of Publication

  • 2022 (4)
  • (-) 2021 (18)
  • 2020 (19)
  • 2019 (7)
  • 2018 (9)
  • (-) 2017 (12)
  • 2016 (19)
  • 2015 (8)
  • 2014 (7)
  • 2013 (6)
  • 2012 (4)
  • 2011 (4)
  • 2010 (1)
  • 2009 (3)
  • 2008 (5)
  • 2007 (2)
  • 2006 (4)
  • 2005 (5)
  • 2004 (1)
  • 2001 (4)
  • 2000 (5)
  • 1999 (4)
  • 1998 (2)
  • 1996 (2)
  • 1995 (2)
  • 1994 (5)
  • 1993 (4)
  • 1992 (6)
  • 1991 (4)
  • 1990 (4)
  • 1989 (1)
  • 1988 (1)
  • 1987 (1)
  • 1986 (1)
  • 1985 (2)
  • 1984 (1)
  • 1983 (6)
  • 1982 (2)
  • 1981 (1)
  • 1979 (1)
  • 1978 (4)
  • 1974 (1)
  • 1966 (1)

Language

  • English (29)
  • Portuguese (1)

Regional focus

  • African Region (AFR) (3)
    • Malawi (2)
  • Eastern Mediterranean Region (EMR) (1)
  • European Region (EUR) (1)
  • Region of the Americas (AMR) (7)
    • Brazil (5)
    • Paraguay (1)
  • South-East Asia Region (SEAR) (8)
    • Bangladesh (1)
    • India (6)
  • Western Pacific Region (WPR) (1)
 
  • Relevance
  • Date
30 items

Publication

Chronic recalcitrant erythema nodosum leprosum: therapeutic dilemma and role of mycobacterium indicus pranii vaccine.

Gupta S, Kumari S. Anais brasileiros de dermatologia. 2021;
Download PDF

Publication

Quali-quantitative synthesis of the global scenario of patent families about leprosy.

Meneghin R. Ciencia & saude coletiva. 2021; 26 (11) : 5411-5426.
Download PDF

Publication

Leprosy: what is new.

Randhawa A, Kapila R, Schwartz R. International journal of dermatology. 2021;

Publication

Cost-effectiveness of incorporating vaccine to multidrug therapy in newly diagnosed leprosy cases for better treatment outcomes & immunoprophylaxis in contacts as leprosy control measures for National Leprosy Eradication Programme in India.

Muniyandi M, Singh M, Singh M, et al. The Indian journal of medical research. 2021; 154 (1) : 121-131.
Download PDF

Publication

BCG-induced immunity profiles in household contacts of leprosy patients differentiate between protection and disease.

van Hooij A, van den Eeden S, Khatun M, et al. Vaccine. 2021;
Download PDF

Publication

BCG and the risk of leprosy in Ciudad del Este, Paraguay, 2016-2017.

Cuevas N, Cardenas V. Epidemiology and health. 2021;
Download PDF

Publication

BCG re-vaccination in Malawi: 30-year follow-up of a large, randomised, double-blind, placebo-controlled trial.

Glynn J, Fielding K, Mzembe T, et al. The Lancet. Global health. 2021; 9 (10) : e1451-e1459.
Download PDF

Publication

Mycobacterium indicus pranii vaccine immunoprophylaxis in anti-phenolic glycolipid-1-positive leprosy contacts - A pilot study from a tertiary care center in North India.

Sendhil Kumaran M, Narang T, Chabbra S, et al. Indian journal of dermatology, venereology and leprology. 2021;
Download PDF

Publication

Efficacy of chemoprophylaxis and immunoprophylaxis in leprosy prevention: a systematic review and network meta-analysis of randomized controlled trials.

Tawfik G, Biala M, Yousef Y, et al. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2021;
Download PDF

Publication

The influence of leprosy-related clinical and epidemiological variables in the occurrence and severity of COVID-19: A prospective real-world cohort study.

Cerqueira S, Deps PD, Cunha D, et al. PLoS neglected tropical diseases. 2021; 15 (7) : e0009635.
Download PDF

Publication

The effect of BCG revaccination on all-cause mortality beyond infancy: 30-year follow-up of a population-based, double-blind, randomised placebo-controlled trial in Malawi.

Glynn J, Dube A, Fielding K, et al. The Lancet. Infectious diseases. 2021;
Download PDF

Publication

Mycobacterium leprae transmission characteristics during the declining stages of leprosy incidence: A systematic review.

Hambridge T, Chandran S, Geluk A, et al. PLoS neglected tropical diseases. 2021; 15 (5) : e0009436.
Download PDF

Publication

All mycobacteria are inventive, but some are more Daedalean than others.

Geluk A. Immunological reviews. 2021;
Download PDF

Publication

INCIDÊNCIA DE CASOS DE HANSENÍASE E A COBERTURA VACINAL DO BCG: CAMINHOS OPOSTOS NO BRASIL

Contin VP, De Moura GV, Bigolin LDL, et al. Revista Multidisciplinar em Saúde. Anais do Congresso Brasileiro de Imunologia On-line. 2021;

Publication

Reverse vaccinology and subtractive genomics approaches for identifying common therapeutics against Mycobacterium leprae and Mycobacterium lepromatosis.

Jaiswal A, Tiwari S, Jamal S, et al. The journal of venomous animals and toxins including tropical diseases. 2021;
Download PDF

Publication

Towards zero leprosy. Global leprosy (‎Hansen’s Disease)‎ strategy 2021–2030

World Health Organization . 2021;
Download PDF

Publication

Recurrent Erythema Nodosum Leprosum Associated With Mycobacterium Indicus Pranii Vaccine In A Case Of Leprosy: A Rare paradox.

Kothari R, Vashisht D, Pudasaini N, et al. Journal of the European Academy of Dermatology and Venereology : JEADV. 2021;

Publication

Leprosy incidence and risk estimates in a 33-year contact cohort of leprosy patients.

Hacker MA, Sales A, Duppre NC, et al. Scientific reports. 2021; 11 (1) : 1947.
Download PDF

Publication

Developing and financing neglected disease vaccines in our new era of "blue marble health" and the anthropocene epoch.

Hotez P. Vaccine. 2017;

Publication

Making of an immuno therapeutic cum immuno prophylactic vaccine against leprosy endowed with multiple properties and useful applications

Talwar G P, Zaheer S A, Gupta S, et al. Journal of medical discovery. 2017; 2 (4) : 1-8.
Download PDF

Pagination

  • Current page 1
  • Page 2
  • Next page Next ›
  • Last page Last »

Use Ris for EndNote, Mendeley, RefWorks, Zotero and most other reference management software.

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications
  • Organizations

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

  • infontd

© 2022 InfoNTD